Istradefylline 20 mg, 40 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 20 mg, 40 mg
Reference Brands: Nourianz(USA)
Category: Neurology
Istradefylline is a Neurology product available as Tablets in strengths 20 mg, 40 mg. It corresponds to the reference brand Nourianz(USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Istradefylline, marketed under the brand name Nourianz, is an oral medication used as an adjunctive treatment for adults with Parkinson’s disease who experience “off” episodes while on levodopa/carbidopa therapy. These “off” episodes are periods when the primary Parkinson’s medications are not providing adequate symptom control, leading to worsening motor symptoms such as tremor, stiffness, and difficulty walking. Istradefylline functions as a selective adenosine A2A receptor antagonist, targeting pathways that help regulate motor control and reduce the frequency and duration of these off periods. By adding istradefylline to existing levodopa/carbidopa therapy, patients may experience more consistent symptom relief and improved daily functioning. The medication is administered orally in 20 mg or 40 mg tablets, under the guidance of a healthcare professional, with dosing individualized based on patient response and tolerance. Istradefylline is generally well tolerated, with reported adverse effects including mild dyskinesia, dizziness, constipation, and insomnia, while serious liver toxicity is rare. Its mechanism and targeted action make it a valuable treatment option for Parkinson’s patients seeking improved motor symptom management during long-term levodopa therapy.
Istradefylline — third party manufacturing & bulk supply
Istradefylline 20 mg, 40 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Istradefylline is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Istradefylline listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Istradefylline →Frequently Asked Questions
Istradefylline is used as an adjunctive treatment for Parkinson’s disease in adults experiencing “off” episodes while on levodopa/carbidopa therapy.
It is a selective adenosine A2A receptor antagonist that helps improve motor control in Parkinson’s patients.
The trade name is Nourianz.
It is manufactured by Kyowa Kirin.
The generic name is istradefylline.
The brand name is Nourianz.
It is manufactured in facilities meeting international pharmaceutical regulatory standards.
Related Products
Valproic Acid
Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
View DetailsQuick Response Guaranteed | Verified Suppliers